Research suggests that the evidence specifically linking turmeric or its active compound curcumin to brain health outcomes is not directly addressed by the studies available here, which instead span a range of other areas including liver function, blood sugar regulation, COVID-19 outcomes, and general spice consumption patterns. The available studies include randomized controlled trials, a meta-analysis, observational and survey-based research, and bibliometric analyses, and while some findings — such as a drug-wide association study noting turmeric among supplements observationally linked to reduced COVID-19 severity — hint at broader systemic effects, none of these studies specifically examined cognitive function, neurological outcomes, or brain health markers. Studies indicate general interest in curcumin's anti-inflammatory and antioxidant properties as a rationale for investigating its effects across multiple conditions, including a survey noting turmeric among supplements used by people with Parkinson's disease, though no clinical trial data on brain-specific outcomes were present in this collection. Taken together, the research base here is insufficient to draw conclusions about turmeric's effects on brain health, and readers interested in this specific application would need to look to studies designed with neurological or cognitive endpoints as their primary focus.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Long-Term Safety and Efficacy of a Highly Purified Plant-Based Nutraceutical ... | Other | 2025 | Neutral | 67 |
| A SYSTEMATIC REVIEW AND META-ANALYSIS ON THE EFFECT OF CURCUMIN (TURMERIC) ON... | Other | 2023 | Neutral | 62 |
| Plant-based natural products for symptomatic relief of Parkinson’s disease: p... | Other | 2023 | Mixed | 57 |
| Relation of spice consumption with COVID-19 first wave statistics (infection,... | Other | 2022 | Neutral | 52 |
| EuroQol-5D-3L in Long Covid patients After Supplementation with EchA Marine<s... | Other | 2023 | Neutral | 47 |
| Heavy Metals Induced Health Risk Assessment Through Consumption of Selected C... | Other | 2023 | Neutral | 42 |
| COVID-19 and Curcumin: Using VOSviewer software to explore scientific landsca... | Other | 2022 | Neutral | 37 |
| AYUSH medicine as add-on therapy for mild category COVID-19; an open label ra... | Other | 2020 | — | 32 |
| Use of antimicrobials during the COVID-19 pandemic: a qualitative study among... | Other | 2023 | Neutral | 27 |
| DrugWAS: Leveraging drug-wide association studies to facilitate drug repurpos... | Other | 2021 | Neutral | 22 |
| Long Covid: quantitative and qualitative analyses of online Long Haulers’ exp... | Other | 2020 | Neutral | 17 |
| Use of medicinal plants for COVID-19 prevention and respiratory symptom treat... | Other | 2021 | Neutral | 12 |